EP3556775
MÓTEFNI GEGN LAG-3 TIL AÐ MEÐHÖNDLA BLÓÐKRABBAMEIN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.1.2015EP published:
17.11.2021EP application number:
19161885.9
EP translation filed:
28.12.2021Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
25.1.2035Expiry date:
25.1.2027Next due date:
31.1.2027
Title in English:
ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIESLanguage of the patent:
English
Timeline
Today
26.1.2015EP application
17.11.2021EP Publication
28.12.2021Translation submitted
15.2.2022Registration published
25.1.2027Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
GUTIERREZ, Andres A.Address:
Princeton, NJ 08543, US
Name:
GROSSO, JosephAddress:
Princeton, NJ 08543, US
Name:
HILL, Christopher MarkAddress:
Seattle, WA 98102, US
Name:
SELBY, MarkAddress:
Redwood City, CA 94063, US
Name:
LEWIS, Katherine E.Address:
Seattle, WA 98102, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201461932589 PDate:
28.1.2014Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 28.12.2021
Expires: 25.1.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 13.12.2022
Expires: 25.1.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.12.2023
Expires: 25.1.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.12.2024
Expires: 25.1.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.1.2026
Expires: 25.1.2027
Payer: Árnason Faktor ehf.